Product Launch (Blog)

Jun, 27 2023

Precision in the Operating Room: Transforming Cancer Treatment with Intraoperative Radiation Therapy


IORT has demonstrated its effectiveness in treating a variety of tumors and cancers, including soft-tissue tumors, recurrent colorectal cancers, and gynecological cancers. It has been noted that regional nodes were treated with IORT in 57.7% of cases and the primary site with IORT in 42.5% of cases. As a consequence of the ability to finish the entire course of radiotherapy during surgery, it has recently become a popular treatment choice for some early-stage breast cancers. Additionally, it is anticipated that a rise in the widespread adoption of minimally invasive procedures, which primarily rely on the imaging supply chain, will foster market growth.

According to Data Bridge Market Research, Intraoperative Radiation Therapy Market was USD 283.94 million in 2022, would rise to USD 498.91 million by 2030 and is expected to undergo a CAGR of 7.30% during the forecast period from 2023 to 2030.

“Increasing incidence of cancer surge market demand"

The increasing incidence of cancer globally is a key driver for the intraoperative radiation therapy market. With the rising prevalence of various types of cancer, there is a growing need for effective treatment options. Intraoperative radiation therapy provides the advantage of delivering targeted radiation directly to the tumor site during surgery, which can lead to more precise and effective cancer treatment. This approach enables better tumor control, minimizes damage to surrounding healthy tissues, and improves patient outcomes, making it a valuable tool in the fight against cancer.

What restraints the growth of the intraoperative radiation therapy market?

“High cost can impede the market growth”

The high cost of implementing and maintaining intraoperative radiation therapy systems is a significant restraint in the market. The complex nature of this treatment modality necessitates advanced equipment and trained personnel, contributing to its high cost. This can restrict its accessibility, especially for healthcare facilities with limited financial resources. Lowering costs and providing cost-effective solutions, such as equipment leasing or shared facilities, can help overcome this barrier and improve the adoption of intraoperative radiation therapy.

Segmentation: Global Intraoperative Radiation Therapy Market  

The intraoperative radiation therapy market is segmented on the basis of method, product, type, application, end user, and distribution channel

  • On the basis of method, the intraoperative radiation therapy market is segmented into electron, intraoperative brachytherapy, high dose-rate, x-ray, and others.
  • On the basis of product, the intraoperative radiation therapy market is segmented into intraoperative radiation therapy devices, intraoperative radiation therapy accessories, and software and services.
  • On the basis of type, the intraoperative radiation therapy market is segmented into portable and benchtop.
  • On the basis of application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, head and neck cancer, soft tissue sarcoma, pediatric tumors, gynecological cancer, genitourinary cancers, and upper gastro-intestinal tumors other cancer.
  • On the basis of end user, the intraoperative radiation therapy market is segmented into hospital, ambulatory surgical centers, specialty center, and others.
  • On the basis of distribution channel, the intraoperative radiation therapy market is segmented into direct tender and retail sales.

Regional Insights: North America dominates the Global Intraoperative Radiation Therapy Market  

North America's dominance in the intraoperative radiation therapy market can be attributed to several factors. The region boasts a large number of market players who consistently introduce new products, invest in research and development, and strive to enhance operational efficiency. Additionally, their focus on developing authentic medical-grade imaging systems ensures the availability of advanced technologies for intraoperative radiation therapy. These factors contribute to North America's leading position in the market.

To know more about the study, visit,

Recent Development in Global Intraoperative Radiation Therapy Market  

  • In 2021, In order to reduce the prevalence of cancer worldwide, Varian Medical Systems, Inc. signed a contract with Australia's Icon Group to supply 30 linear accelerators and related treatment software. This will help the company increase access to care in underserved rural areas of Australia and Asia.

 The Prominent Key Players Operating in the Global Intraoperative Radiation Therapy Market   Include:

  • IntraOp Medical, Inc (U.S.)
  • Varian Medical Systems, Inc (U.S.)
  • Eckert & Ziegler (Germany)
  • Sensus Healthcare (U.S.)
  • Elekta (Sweden)
  • REMEDI Co.,Ltd(South Korea)
  • Brainlab AG (Germany)
  • Sensus Healthcare (U.S.)
  • Elekta (Sweden)

Above are the key players covered in the report, to know about more and exhaustive list of global intraoperative radiation therapy market   companies contact,

Research Methodology: Global Intraoperative Radiation Therapy Market  

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.

Client Testimonials